NASDAQ:ADXS
Delisted

Advaxis Stock Predictions

etoro logo Buy ADXS
*Your capital is at risk
$0.604
+0 (+0%)
At Close: May 01, 2026
Currently predicting for Mon, 8 Jun 2026

ADXS Prediction Chart

ADXS Predictions History

Latest community submissions for ADXS.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jul 26, 2021 $0.406 -98.76% $0.408 V 99.44% 4
Jul 26, 2021 $0.400 -98.78% $0.408 V 97.97% 1
Jul 7, 2021 Bullish $0.507 X 0
Cherie Lynn Auletta Cherie Lynn Auletta @CherieLynnAuletta.210168
Jul 7, 2021 Bearish $0.507 V 1
Jul 7, 2021 Bearish $0.507 V 1
JS JS Pro
Jan 20, 2021 $0.698 -98.74% $0.692 V 99.13% 3
Baltzera Baltzera Merchant
Jan 20, 2021 Bearish $0.692 V 1
JS JS Pro
Jan 19, 2021 $0.593 -98.97% $0.718 V 82.64% 0
Jan 19, 2021 Bullish $0.718 X 1
JS JS Pro
Nov 12, 2020 $0.393 -98.75% $0.394 V 99.67% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ADXS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ADVAXIS
Advaxis
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE